NasdaqCM - Delayed Quote USD
Aadi Bioscience, Inc. (AADI)
At close: November 21 at 4:00 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. David J. Lennon Ph.D. | President, CEO & Director | 277.75k | -- | 1971 |
| Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications | 643.23k | -- | 1970 |
| Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel | -- | -- | 1976 |
| Mr. Raymond G. Steitz | Senior VP of Human Resources & Chief Human Resources Officer | -- | -- | 1959 |
| Mr. Bryan Ball | Chief Technical Operations Officer | -- | -- | 1970 |
Aadi Bioscience, Inc.
17383 Sunset Boulevard
Suite A250
Pacific Palisades, CA 90272
United States
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 53
Description
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Corporate Governance
Aadi Bioscience, Inc.’s ISS Governance QualityScore as of November 1, 2024 is 7. The pillar scores are Audit: 3; Board: 6; Shareholder Rights: 8; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 6, 2024 at 1:00 PM UTC
Aadi Bioscience, Inc. Earnings Date
Recent Events
Related Tickers
KRON Kronos Bio, Inc.
0.8743
+1.66%
IPSC Century Therapeutics, Inc.
1.2400
-1.59%
ASMB Assembly Biosciences, Inc.
14.72
-2.00%
ANTX AN2 Therapeutics, Inc.
1.2300
-5.38%
ACHL Achilles Therapeutics plc
1.0700
0.00%
OKUR OnKure Therapeutics, Inc.
15.99
-0.06%
SEER Seer, Inc.
2.3800
+3.93%
TBPH Theravance Biopharma, Inc.
9.61
-3.61%
NXTC NextCure, Inc.
1.2900
-0.77%
GLTO Galecto, Inc.
5.85
-1.60%